Calton & Associates’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Hold
0
– – – 400
2026
Q1
– Sell
-9,546
Closed -$232K – 459
2025
Q4
$232K Sell
9,546
-659
-6% -$16K 0.03% 391
2025
Q3
$248K Buy
10,205
+659
+7% +$16K 0.04% 365
2025
Q2
$232K Sell
9,546
-1,250
-12% -$30.2K 0.04% 338
2025
Q1
$261K Buy
+10,796
New +$260K 0.06% 262

Other funds holding IBDS

Calton & Associates's IBDS Position: Q2 2026 in Review

Calton & Associates held its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) position steady in Q2 2026 at 0 shares worth $210K. The position accounts for 0.03% of the portfolio, ranked #400.

Calton & Associates first reported a position in IBDS in Q1 2025 and has held it in 4 quarters since. The position peaked at $261K in Q1 2025. 416 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

  • Calton & Associates held 0 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $210K as of Q2 2026.
  • Calton & Associates left its iShares iBonds Dec 2027 Term Corporate ETF share count unchanged in Q2 2026.
  • iShares iBonds Dec 2027 Term Corporate ETF made up 0.03% of Calton & Associates's portfolio in Q2 2026, its #400 holding.
  • Calton & Associates first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q1 2025 and has held it in 4 quarters since.
  • Calton & Associates's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $261K in Q1 2025.
  • 416 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on Calton & Associates's 13F filing for Q2 2026, filed 10 Aug 2026.